What question did this study set out to answer?

This research aims to evaluate if urinary isoxanthopterin can serve as a marker for fasting hyperglycemia linked to xanthine oxidase activity in obese patients with type 2 diabetes.

April 16, 2026Open Access

The urinary Isoxanthopterin/pterin Ratio Reflects Mild Fasting Hyperglycemia in Obese Patients with Type 2 Diabetes Mellitus: An Exploratory Cross-sectional Study

Puntos clave

This research aims to evaluate if urinary isoxanthopterin can serve as a marker for fasting hyperglycemia linked to xanthine oxidase activity in obese patients with type 2 diabetes.
Conducted an exploratory cross-sectional study design.
Measured urinary isoxanthopterin levels and fasting glucose in obese type 2 diabetes patients.
Analyzed the relationship between urinary isoxanthopterin and fasting hyperglycemia.
Identified a significant correlation between urinary isoxanthopterin levels and fasting hyperglycemia.
The urinary isoxanthopterin/pterin ratio provided insights into the oxidative stress related to type 2 diabetes.
Findings indicate potential implications for using urinary markers in diabetes management.

Resumen

Objective The exaggerated activation of xanthine oxidase (XO) provokes oxidative stress, a feature of type 2 diabetes mellitus (T2DM) and obesity. Because measuring the plasma XO activity is complicated, we tested whether urinary isoxanthopterin (IXP), the end product of pterin metabolism catalyzed by XO, could serve as an alternative marker.

Me gusta

Guardar

Ver artículo completo